307 related articles for article (PubMed ID: 28376890)
1. Xeroderma pigmentosum-Cockayne syndrome complex.
Natale V; Raquer H
Orphanet J Rare Dis; 2017 Apr; 12(1):65. PubMed ID: 28376890
[TBL] [Abstract][Full Text] [Related]
2. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.
Moriwaki S; Stefanini M; Lehmann AR; Hoeijmakers JH; Robbins JH; Rapin I; Botta E; Tanganelli B; Vermeulen W; Broughton BC; Kraemer KH
J Invest Dermatol; 1996 Oct; 107(4):647-53. PubMed ID: 8823375
[TBL] [Abstract][Full Text] [Related]
3. Cockayne syndrome and xeroderma pigmentosum.
Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
[TBL] [Abstract][Full Text] [Related]
4. Xeroderma Pigmentosum - Cockayne Syndrome Complex (XP-CS) - Another case.
Metlo A; Rehan A; Akmal M; Iqbal U; Jamali M
J Pak Med Assoc; 2018 Oct; 68(10):1531-1534. PubMed ID: 30317357
[TBL] [Abstract][Full Text] [Related]
5. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy.
Kleijer WJ; Laugel V; Berneburg M; Nardo T; Fawcett H; Gratchev A; Jaspers NG; Sarasin A; Stefanini M; Lehmann AR
DNA Repair (Amst); 2008 May; 7(5):744-50. PubMed ID: 18329345
[TBL] [Abstract][Full Text] [Related]
6. Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical features.
Fujimoto M; Leech SN; Theron T; Mori M; Fawcett H; Botta E; Nozaki Y; Yamagata T; Moriwaki S; Stefanini M; Momoi MY; Nakagawa H; Shuster S; Moss C; Lehmann AR
J Invest Dermatol; 2005 Jul; 125(1):86-92. PubMed ID: 15982307
[TBL] [Abstract][Full Text] [Related]
7. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
Itoh T
J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
[TBL] [Abstract][Full Text] [Related]
8. [Cockayne Syndrome].
Moriwaki S
Brain Nerve; 2019 Apr; 71(4):390-393. PubMed ID: 30988227
[TBL] [Abstract][Full Text] [Related]
9. Elevated Urinary Levels of 8-Hydroxy-2'-deoxyguanosine in a Japanese Child of Xeroderma Pigmentosum/Cockayne Syndrome Complex with Infantile Onset of Nephrotic Syndrome.
Kondo D; Noguchi A; Tamura H; Tsuchida S; Takahashi I; Kubota H; Yano T; Oyama C; Sawaishi Y; Moriwaki S; Takahashi T
Tohoku J Exp Med; 2016 Jul; 239(3):231-5. PubMed ID: 27396511
[TBL] [Abstract][Full Text] [Related]
10. Xeroderma pigmentosum complementation group G associated with Cockayne syndrome.
Vermeulen W; Jaeken J; Jaspers NG; Bootsma D; Hoeijmakers JH
Am J Hum Genet; 1993 Jul; 53(1):185-92. PubMed ID: 8317483
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of xeroderma pigmentosum and Cockayne syndrome.
Cleaver JE; Volpe JP; Charles WC; Thomas GH
Prenat Diagn; 1994 Oct; 14(10):921-8. PubMed ID: 7534923
[TBL] [Abstract][Full Text] [Related]
12. U.V. enhanced reactivation of U.V.-and gamma-irradiated adenovirus in Cockayne syndrome and Xeroderma pigmentosum fibroblasts.
Jeeves WP; Rainbow AJ
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Jun; 43(6):625-47. PubMed ID: 6343275
[TBL] [Abstract][Full Text] [Related]
13. [The determination of the complementation groups for the cells of patients with xeroderma pigmentosum and the Cockayne syndrome found in Russia].
Pleskach NM; Mikhel'son VM; Raams A; Bootsma D
Tsitologiia; 1996; 38(8):863-8. PubMed ID: 9027016
[TBL] [Abstract][Full Text] [Related]
14. Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia.
Kashiyama K; Nakazawa Y; Pilz DT; Guo C; Shimada M; Sasaki K; Fawcett H; Wing JF; Lewin SO; Carr L; Li TS; Yoshiura K; Utani A; Hirano A; Yamashita S; Greenblatt D; Nardo T; Stefanini M; McGibbon D; Sarkany R; Fassihi H; Takahashi Y; Nagayama Y; Mitsutake N; Lehmann AR; Ogi T
Am J Hum Genet; 2013 May; 92(5):807-19. PubMed ID: 23623389
[TBL] [Abstract][Full Text] [Related]
15. Reduced RNA polymerase II transcription in extracts of cockayne syndrome and xeroderma pigmentosum/Cockayne syndrome cells.
Dianov GL; Houle JF; Iyer N; Bohr VA; Friedberg EC
Nucleic Acids Res; 1997 Sep; 25(18):3636-42. PubMed ID: 9278484
[TBL] [Abstract][Full Text] [Related]
16. Pellagra-like condition is xeroderma pigmentosum/Cockayne syndrome complex and niacin confers clinical benefit.
Hijazi H; Salih MA; Hamad MH; Hassan HH; Salih SB; Mohamed KA; Mukhtar MM; Karrar ZA; Ansari S; Ibrahim N; Alkuraya FS
Clin Genet; 2015; 87(1):56-61. PubMed ID: 24354460
[TBL] [Abstract][Full Text] [Related]
17. Oxidative damage-induced PCNA complex formation is efficient in xeroderma pigmentosum group A but reduced in Cockayne syndrome group B cells.
Balajee AS; Dianova I; Bohr VA
Nucleic Acids Res; 1999 Nov; 27(22):4476-82. PubMed ID: 10536158
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum--bridging a gap between clinic and laboratory.
Moriwaki S; Kraemer KH
Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401
[TBL] [Abstract][Full Text] [Related]
19. Minimal ionizing radiation sensitivity in a large cohort of xeroderma pigmentosum fibroblasts.
Arlett CF; Green MH; Rogers PB; Lehmann AR; Plowman PN
Br J Radiol; 2008 Jan; 81(961):51-8. PubMed ID: 18079351
[TBL] [Abstract][Full Text] [Related]
20. [Ocular manifestations in xeroderma pigmentosum].
Süsskind D; Berneburg M; Rohrbach JM
Klin Monbl Augenheilkd; 2011 Mar; 228(3):239-44. PubMed ID: 20799158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
